|
시장보고서
상품코드
2078190
Drug Discovery용 인공지능(AI) 시장 : 치료 분야별, 용도별, 지역별Artificial Intelligence in Drug Discovery Market, By Therapeutic Space, By Application, By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) |
||||||
Drug Discovery용 인공지능(AI) 시장 규모는 2026년에 19억 7,080만 달러로 추정되며, 2033년까지 55억 7,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 16.0%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 19억 7,080만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 16.00% | 예측 금액(2033년) | 55억 7,000만 달러 |
인공지능(AI)이란, 지능을 가진 기계, 특히 지능을 가진 컴퓨터 프로그램을 구축하기 위한 과학 및 공학을 말합니다. AI 기술은 신약 개발, 의약품 개발, 기존 의약품의 새로운 용도 개발(리퍼퍼싱), 약물 대사 예측, 약물 독성 분석, 제약 생산성 향상, 임상시험, 그리고 약학의 거의 모든 측면에 적용될 수 있습니다. 이러한 기술들은 모두 AIDD(Drug Discovery용 인공지능)라는 틀 아래에서 총칭되고 있습니다.
시장 역학:
기술 발전, 시장 진입 기업들의 신제품 출시, 제휴, 연구개발 계약, 그리고 시장 참여자들의 기타 비유기적 성장 전략은 예측 기간 동안 전 세계 Drug Discovery용 인공지능(AI) 시장의 성장을 촉진할 것으로 예상되는 주요 요인입니다.
예를 들어, 2023년 5월 16일, Google Cloud는 'Bio-IT World Conference'에서 생명공학 기업, 제약사 및 공공 부문 기관을 대상으로 신약 개발과 정밀 의학을 가속화할 두 가지 새로운 AI 기반 생명과학 솔루션을 발표했습니다. 'Target and Lead Identification Suite'는 연구자가 아미노산의 기능을 보다 정확하게 규명하고, 단백질의 구조를 예측하는 데 도움이 됩니다. 또한, 'Multiomics Suite'는 유전체 데이터의 발견과 해석을 가속화하여 기업이 정밀 치료법을 설계할 수 있도록 지원합니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 전 세계 Drug Discovery용 인공지능(AI) 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 소개하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 Drug Discovery용 인공지능(AI) 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 Drug Discovery용 인공지능(AI) 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 Drug Discovery용 인공지능(AI) 시장
제5장 Drug Discovery용 인공지능(AI) 시장 : 치료 분야별(2021-2033년)
제6장 Drug Discovery용 인공지능(AI) 시장 : 용도별(2021-2033년)
제7장 Drug Discovery용 인공지능(AI) 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
KSM 26.07.14Artificial Intelligence in Drug Discovery Market is estimated to be valued at USD 1,970.8 Mn in 2026 and is expected to reach USD 5,570.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 16.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,970.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 16.00% | 2033 Value Projection: | USD 5,570.0 Mn |
The Artificial intelligence (AI) is the science and engineering of making intelligent machines, especially intelligent computer programs. The AI techniques are also applicable to drug discovery, drug development, drug repurposing, drug metabolism prediction, drug toxicity analysis, improving pharmaceutical productivity, clinical trials and almost all aspects of pharmaceutical sciences. All these techniques are collectively considered under AIDD (Artificial Intelligence in Drug Discovery).
Market Dynamics:
Increasing technological advancements, product launches by market players, collaborations, research and development agreements and other inorganic growth strategies by market players are major factors expected to augment growth of the global artificial intelligence in drug discovery market over the forecast period.
For instance, on May 16 2023, Google Cloud, in Bio-IT World Conference announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. The Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Multiomics Suite accelerates the discovery and interpretation of genomic data, helping companies design precision treatments.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global artificial intelligence in drug discovery market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include IBM Corporation (Ibm Watson Health), Exscientia, GNS Healthcare, Alphabet, Inc. (DEEPMIND), Benevolent AI, Biosymetrics, Euretos, Berg LLC., Atomwise, Inc., among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global artificial intelligence in drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in drug discovery market.
Detailed Segmentation:
- Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Space (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Infectious Diseases
- Other
- Global Artificial Intelligence in Drug Discovery Market, By Application (Revenue, USD Mn, 2021 - 2033)
- Drug Optimization & Repurposing
- Preclinical Testing
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- IBM Corporation (Ibm Watson Health)
- Exscientia
- GNS Healthcare
- Alphabet, Inc. (DEEPMIND)
- Benevolent AI
- Biosymetrics
- Euretos
- Berg LLC.
- Atomwise, Inc.
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Therapeutic Space
- Market Snapshot, By Application
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising need to curb drug development and discovery costs
- Rising prevalence of chronic diseases supporting development of personalized drugs
- Big data and information explosion in healthcare and drug discovery
- Growing applications of AI in various healthcare areas
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Artificial Intelligence in Drug Discovery Market
- Supply Side and Demand Side Analysis
- Economic Impact
5. Artificial Intelligence in Drug Discovery Market, By Therapeutic Space, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Neurodegenerative Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Metabolic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Artificial Intelligence in Drug Discovery Market, By Application, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Drug Optimization & Repurposing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Preclinical Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
7. Artificial Intelligence in Drug Discovery Market, By Geography, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
8. Competitive Landscape
- IBM Corporation (Ibm Watson Health)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Exscientia
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GNS Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alphabet, Inc. (DEEPMIND)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Benevolent AI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biosymetrics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Euretos
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Berg LLC.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Atomwise, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
